Bhubaneswar: About 20 per cent of people in Odisha have not developed antibodies despite taking two doses of COVID vaccines.
Life Sciences (ILS) director Ajay Parida told the media on Saturday that this has come to light following genome sequencing by the institute.
He said the ILS here had conducted genome sequencing of 600 samples in August this year and identified 425 Delta variants and other variants of COVID-19. However, no new mutation was found.
He further said as genome sequencing has revealed that 20 per cent of people have not developed antibodies against COVID-19 despite taking two doses of vaccines, a study is underway to determine whether a third dose or a booster dose is required.
If there is a requirement, it will be studied whether the people would be given the vaccines of the same company they had taken earlier or they need the vaccines of other companies.
Kolkata: Chief Minister Mamata Banerjee on Monday increased the salaries of senior resident doctors serving… Read More
Bhubaneswar: Advanced AI-powered CCTV cameras with facial recognition capabilities will be installed by the police… Read More
Bhubaneswar: After considerable drop in temperature across Odisha following rain in last few days, the… Read More
New Delhi: Vasundhara Oswal, daughter of Indian-origin billionaire Pankaj Oswal, has raised allegations of causing… Read More
New Delhi: After a prod by the Delhi High Court, Indian Railways has started monitoring… Read More
Bhubaneswar: The Economic Offences Wing (EOW) of Odisha arrested a man from Hyderabad for allegedly… Read More
This website uses cookies.